Michael A Cerqueira1, Karen L Ferrari1, Amilcar C de Mattos1, Carlos R Monti1, Leonardo Oliveira Reis2. 1. UroScience, Pontifical Catholic University of Campinas (PUC-Campinas), Radium Institute and School of Medical Sciences, University of Campinas, Unicamp, Rua: John Boyd Dunlop, s/n, Campinas, Sao Paulo, 13060-904, Brazil. 2. UroScience, Pontifical Catholic University of Campinas (PUC-Campinas), Radium Institute and School of Medical Sciences, University of Campinas, Unicamp, Rua: John Boyd Dunlop, s/n, Campinas, Sao Paulo, 13060-904, Brazil. reisleo.l@gmail.com.
Abstract
PURPOSE: Tumors escape from the immune system by decreasing CD8+ and increasing CD4+ T cells' activity, druggable targets. Thermal ablation might activate tumor-specific T cells by raising the presentation of tumor-specific antigens and hindering tumor negative immune regulation. Our aim was to assess T cell infiltrate pre- and post-cryoablation in a prospective observational study. METHODS: A total of 240 sextant prostate biopsies cores (12 cores/patient) were collected from 10 unilateral prostate cancer patients (T1c, PSA density < 0.15 ng/dL, Gleason grade group 1, ≤ 2 cancer biopsy cores, and < 50% cancer core involvement) at diagnosis and 12 months after hemi-cryoablation. Cancer-positive (Diag+) and cancer-negative (Diag-) lobes at diagnosis and the same areas 12 months after hemi-cryoablation (Cryo+ and Cryo-, respectively) were explored by immunohistochemistry for infiltrating CD4+ and CD8+ T cells (in 45 random fields per prostate lobe, 400× magnification). The quantitative analysis of cells/mm2 and CD4+/CD8+ ratio were performed and compared among Diag+, Diag-, Cryo+, and Cryo- using ImageJ software. RESULTS: There was a significant increase in tumor-infiltrating CD8+ T cells/mm2 in the Cryo+ tissue (mean, SD 0.31, 0.30) compared to Diag+ (0.18, 0.15), p = 0.015; confirmed in prostate acini (hot spots), p = 0.029, in which infiltrating CD4+/CD8+ T cells' ratio decreased after hemi-cryoablation, p = 0.006. Infiltrating CD4+ T cells/mm2 presented a trend to decrease in Cryo+ (0.26, 0.27) compared to Diag+ (0.38, 0.32). CONCLUSIONS: This is the first study to show local immune modulation after prostate cancer cryoablation, characterized by decreasing CD4+/CD8+ T cells' ratio, potential for clinical impact by unleashing the T-cell response to cancer. Future studies are necessary to explore different energies and longer follow-up clinical endpoints.
PURPOSE:Tumors escape from the immune system by decreasing CD8+ and increasing CD4+ T cells' activity, druggable targets. Thermal ablation might activate tumor-specific T cells by raising the presentation of tumor-specific antigens and hindering tumor negative immune regulation. Our aim was to assess T cell infiltrate pre- and post-cryoablation in a prospective observational study. METHODS: A total of 240 sextant prostate biopsies cores (12 cores/patient) were collected from 10 unilateral prostate cancerpatients (T1c, PSA density < 0.15 ng/dL, Gleason grade group 1, ≤ 2 cancer biopsy cores, and < 50% cancer core involvement) at diagnosis and 12 months after hemi-cryoablation. Cancer-positive (Diag+) and cancer-negative (Diag-) lobes at diagnosis and the same areas 12 months after hemi-cryoablation (Cryo+ and Cryo-, respectively) were explored by immunohistochemistry for infiltrating CD4+ and CD8+ T cells (in 45 random fields per prostate lobe, 400× magnification). The quantitative analysis of cells/mm2 and CD4+/CD8+ ratio were performed and compared among Diag+, Diag-, Cryo+, and Cryo- using ImageJ software. RESULTS: There was a significant increase in tumor-infiltrating CD8+ T cells/mm2 in the Cryo+ tissue (mean, SD 0.31, 0.30) compared to Diag+ (0.18, 0.15), p = 0.015; confirmed in prostate acini (hot spots), p = 0.029, in which infiltrating CD4+/CD8+ T cells' ratio decreased after hemi-cryoablation, p = 0.006. Infiltrating CD4+ T cells/mm2 presented a trend to decrease in Cryo+ (0.26, 0.27) compared to Diag+ (0.38, 0.32). CONCLUSIONS: This is the first study to show local immune modulation after prostate cancer cryoablation, characterized by decreasing CD4+/CD8+ T cells' ratio, potential for clinical impact by unleashing the T-cell response to cancer. Future studies are necessary to explore different energies and longer follow-up clinical endpoints.
Entities:
Keywords:
Ablation; Prostate cancer; Tumor microenvironment; Tumor-infiltrating T cells
Authors: Brunno C F Sanches; Ana Luiza Lalli; Wilmar Azal Neto; Athanase Billis; Leonardo Oliveira Reis Journal: World J Urol Date: 2018-03-01 Impact factor: 4.226
Authors: Taimur T Shah; Veeru Kasivisvanathan; Charles Jameson; Alex Freeman; Mark Emberton; Hashim U Ahmed Journal: World J Urol Date: 2015-05-06 Impact factor: 4.226
Authors: María de la Luz García-Hernández; Norma Ofelia Uribe-Uribe; Ricardo Espinosa-González; W Martin Kast; Shabaana A Khader; Javier Rangel-Moreno Journal: Front Immunol Date: 2017-05-17 Impact factor: 7.561
Authors: John M Baust; Kimberly L Santucci; Robert G Van Buskirk; Isaac Raijman; William E Fisher; John G Baust; Kristi K Snyder Journal: Biomedicines Date: 2022-02-15
Authors: Petros X E Mouratidis; Marcia Costa; Ian Rivens; Elizabeth E Repasky; Gail Ter Haar Journal: J R Soc Interface Date: 2021-07-07 Impact factor: 4.118
Authors: Erika Heninger; Nan Sethakorn; David Kosoff; Peiman Hematti; Morgan D Kuczler; Kenneth J Pienta; Joshua M Lang Journal: Oncotarget Date: 2020-11-17